FDA Inspection 1008835 — Michaela Liedtke, MD

Michaela Liedtke, MD — FEI 3013203582

The FDA completed an inspection of Michaela Liedtke, MD on Mar 24, 2017 in Stanford, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Stanford, CA (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.